Navigation Links
BioMS Medical to present at BioContact 2007
Date:9/28/2007

Toronto Stock Exchange Symbol: MS

EDMONTON, Sept. 28 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Tony Hesby, Executive Vice President Corporate Affairs, will give a corporate presentation at BioContact 2007 in Quebec City.

WHEN: Wednesday 3rd October, 2007 at 2:30pm (EST)

WHERE: Chateau Frontenac, Quebec

About BioMS Medical Corp.

BioMS Medical is a biotechnology company engaged in the development and commercialization of novel therapeutic technologies. BioMS Medical's lead technology, MBP8298, is for the treatment of multiple sclerosis and is being evaluated in two pivotal phase III clinical trials for secondary progressive MS patients, MAESTRO-01 in Canada and Europe and MAESTRO-03 in the United States. It additionally is being evaluated for relapsing remitting MS patients in a Phase II trial in Europe entitled MINDSET-01. For further information please visit our website at http://www.biomsmedical.com.

This news release may contain certain forward-looking statements that reflect the current views and/or expectations of BioMS Medical with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.


'/>"/>
SOURCE BioMS Medical Corp.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Medical College receives $377K to study brain disease
2. Barriers will not stop convergence of medical technologies
3. Medical College team creates website for tracking flu
4. Biomedical engineering conference invites manufacturers
5. Visions: Wade offers straight talk on e-medical records
6. Merge unveils updated medical imaging software
7. Medical College receives $1.4M cancer grant
8. Medical technology firm lands $100K federal grant
9. Doyle outlines spending for Medical College, UWM
10. And the winners in medical design are
11. Manufacturing partnership will move into biotech and biomedical spaces

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... ,, SEATTLE,Nov.24/PRNewswire/--BlueMarbleEn...ublicDevelopmentAuthority(OPDA)wererecentlyawarded...alizationBoard(CERB)inaprivate/publicpartnershipto...ineryinLincolnCounty,WA. ,, "Thisinvestmentwill...dbringover70greenjobstoLincolnCounty,"saidBlueMarb...
(Date:11/24/2009)... ,, TSXVENTURE:HTL , TORONTO,Nov.24/PRN...ormerlyCalottoCapitalInc.,aleadingproviderofadvanc...andfertilityclinicmarkets,todayreportedoperational...r30,2009. , ,Q32009Highlights,-Revenuewas$1.46mi...marginwas66.3percentcomparedwith66.1percentinQ3,20...
(Date:11/24/2009)... ,, REDWOODCITY,Calif.,Nov.24/PRNewswire-Fir...ouncedthatRandyScott,GenomicHealth,sExecutiveChair...reConferenceinNewYorkCityonTuesday,December1,2009a...archivedwebcastofthepresentation,visittheInvestorR...nvestor.genomichealth.com .Pleaseconnecttothewebsi...
(Date:11/24/2009)... , Chemical Abstracts Ser...ion, reports that China,s patent office is now the...ications in chemistry. China trailed Japan,s paten...tion (WIPO), and the United States Patent and Trad...assed the USPTO in 2005, WIPO in 2006, and exceede...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Genomic Health to Present at Piper Jaffray Health Care Conference 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...ylin Pharmaceuticals,Inc. (Nasdaq: AMLN ) will We...y, May 30, 2008 at 11:00 a.m. PT from the company,...ng the Annual Meeting, Daniel M.,Bradbury, Preside...ticals,will be providing a corporate overview., T...ding will be made,available following the event. T...
...wswire/ - ImmunoVaccine Technologies Inc. (IVT), a...mila Philip for being,recognized as one of Pennsyl...ip, Co-Founder and President of Immunotope Inc., r...rd G. Rendell., "Ramila is a champion in the biot...ry for ovarian and breast cancer is inspiring," co...
...wswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:,...it has been granted,Canadian Patent 2,360,833 enti...ferative Disorders." The claims describe the use o...mediated proliferative disorders., "This patent p...ion for,the use of reovirus compositions for cance...
Other Biology Technology:ImmunoVaccine Technologies Congratulates Dr. Ramila Philip as One of PA's Best 50 Women in Business 2Oncolytics Biotech Inc. Announces Issuance of 9th Canadian Patent 2
(Date:11/23/2009)...AMES, Iowa - The only swine vaccine available for ...herd infected with the virus. The vaccination mark...herd diagnosed with the pandemic flu., Iowa Stat...ience, developed the vaccine this summer and has b...n Iowa, Kansas and Illinois for several weeks., ...
(Date:11/23/2009)...DISON, WI, November 16, 2009 -- A USDOE and USDA s...and, idle cropland, and cropland pasture could be ...erennial grasses, such as switchgrass, from which ...edstock. Economically viable production of a peren...tities of biomass are removed annually is expected...
(Date:11/23/2009)...DURHAM, N.H. University of New Hampshire microbio... $498,115 to advance understanding of the actinorh...l to enrich nutrient-poor and contaminated soils. ...USDA) awarded Tisa, a professor of molecular, cell...the symbiotic relationship between the bacteria Fr...
Breaking Biology News(10 mins):Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Switchgrass produces biomass efficiently 2UNH prof. receives nearly $500,000 to research environmentally significant plants 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnersh 14747 1Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnersh 14747 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnersh 14747 3Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 1Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 2Federal Judge Rejects Tobacco Companies Effort to Block Key Provisions of New Tobacco Regulation Law 60808 1Federal Judge Rejects Tobacco Companies Effort to Block Key Provisions of New Tobacco Regulation Law 60808 2
...ool of Tropical Medicine (LSTM) and the University...ject grant to begin the development of new drugs t...llcome Trust, aims to develop new antimalarial dru...e in the respiratory chain of Plasmodium falcipar...me within the parasite is not found in humans, the...
...e University of Vermont Cardiovascular Research In...ased expression in the heart of plasminogen activa...results, which appear in the March 2009 issue of ...1 overexpression, known to accompany insulin resis...g to the high incidence of heart failure after myo...
...3 Military, homeland security, law enforcement an...nited States are being encouraged to attend the 20...VII) in northern Virginia this May 19-21. , , Nea...nty Regional Airport, just south of Marine Corps B...ives survivability demonstrations will be at range...
Other Biology News:LSTM and UoL secure £1.4m ($2m) to develop new 'magic bullet' antimalarial drug 2Plasminogen activator inhibitor type-1 -- a potential link between heart failure and diabetes 2Demonstration Targets Terrorism 2
...Beacon Designer designs oligos for SYBR Green, Taq...on, NASBA and FRET assays. Highly specific primers...y automatically interpreting BLAST search results....e secondary structures identified by connecting to...
Agar (BACTERIOLOGICAL GRADE) from GE Healthcare, formerly Amersham Biosciences
Silencer Validated siRNA 5 nmol from Ambion
SPoT-Light EGFR Probe from Invitrogen
Biology Products: